Development of parallel line analysis criteria for recombinant adenovirus potency assay and definition of a unit of potency

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 3, 2007, Pages 183-193

  Ogawa, Yasushi ^a,b   Fawaz, Farah ^a   Reyes, Candice ^a   Lai, Julie ^a   Pungor Jr , Erno ^a  

^a BAYER AG   (Germany)

^b NONE   (United States)

Author keywords

Adenovirus; Bioassay; Cell culture; Fiducial limit; Parallel line analysis

Indexed keywords

FIBROBLAST GROWTH FACTOR 4;

ADENOVIRUS; ADENOVIRUS 5; ARTICLE; BIOASSAY; CELL CULTURE; COMPUTER PROGRAM; DOSE RESPONSE; HUMAN; LINEAR REGRESSION ANALYSIS; NONHUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STATISTICAL ANALYSIS; TECHNIQUE; TECHNOLOGY; VIRUS GENE; VIRUS STRAIN;

ADENOVIRIDAE; BIOLOGICAL ASSAY; DATA INTERPRETATION, STATISTICAL; FIBROBLAST GROWTH FACTOR 4; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 34547766985     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Zar, J. H. Biostatistical Analysis, 2nd ed.; Prentice Hall: Englewood Cliffs, NJ, 1974; pp 54-56.
2. General Chapter 111. Design and Analysis of Biological Assays. US Pharmacopeia 29; US Pharmacopeial Convention: Rockville, MD, 2006.
3. Chapter 5.3. Statistical Analysis of Results of Biological Assays and Tests. European Pharmacopeia 5.5; European Direcorate for the Quality of Medicines, 2006.
4. Grines, C.; Rubanyi, G. M.; Kleiman, N. S.; Marrott, P.; Watkins, M. W. Angiogenic gene therapy with Adenovirus 5 Fibroblast Growth Factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease. Am. J. Cardiol. 2003, 92, 24-31.
5. Lehmberg, E.; Traina, J. A.; Chakel, J. A.; Chang, R. J.; Parkman, M.; McCaman, M. T.; Murakami, P. K.; Lahidji, V.; Nelson, J. W.; Hancock, W. S.; Nestaas, E.; Pungor, E. Jr. Reversed-phase high performance liquid chromatographic assay for the adenovirus type 5 proteome. J. Chromatogr., B. Biomed. Sci. Appl. 1999, 732 (2), 411-423.
6. McCaman, M.; Castillo, F.; Fawaz, F.; Ogawa, Y.; Whiteley, E.; Lehmberg, E.; Tan, M.; Kung, J.; Mann, B.; Pungor, E. Jr.; Rubanyi, G. M. Adenovirus-based Gene Therapy: Therapeutic Angiogenesis with Adenovirus 5 Fibroblast Growth Factor-4 (Ad5FGF-4) in Patients with Chronic Myocardial Ischemia. Modern Biopharmaceuticals, Design, Development and Optimization; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2005; Vol. 1, pp 151-181.
7. Fawaz, F. S.; Elsheikh, M. A.; Ogawa, Y.; Files, J. G.; McCaman, M. T.; Pungor, E. Jr. A potency assay for a replication incompetent adenovirus type 5 carrying a human fgf-4 gene. Anal. Biochem. 2005, 342, 34-44.
8. Zar, J. H. Biostatistical Analysis, 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1999; pp 360-369.
9. Zar, J. H. Biostatistical Analysis, 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1999; pp 202-204.
10. Zar, J. H. Biostatistical Analysis, 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1999; pp 324-337.
11. Snedecor, G. W.; Cochran, W. G. Statistical Methods, 8th ed.; Iowa State University Press: Ames, IA, 1989; pp 217-231.
12. Zar, J. H. Biostatistical Analysis, 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1999; pp 452-457.